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Abstract Summary: 
      Low frequency ultrasound in combination with 
Sodium Lauryl Sulphate (SLS), a known transdermal 
chemical enhancer has been found to enhance delivery 
of molecules through the skin. In this abstract, we 
report the effects of changing SLS concentration on 
cavitation, protein permeation through the skin and skin 
damage. 
 
Introduction: 
     Low-frequency ultrasound (US), applied to skin via 
a liquid coupling medium, has been shown to enhance 
the permeation of various molecules such as drugs and 
proteins across and into the skin
1
. The main mechanism 
of enhanced permeation is thought to be cavitation – 
formation and collapse of gas bubbles in the coupling 
medium. Violent collapse of gaseous bubbles produces 
shockwaves on the skin surface. It has also been shown 
that chemical enhancers such as sodium lauryl sulphate 
(SLS) can act in synergy with low-frequency US to 
further increase drug permeation into the skin
2, 3
. Tezel 
et al
3
 suggested the synergy by US to be a result of 
increased dispersion to be a result of increased 
dispersion of the chemical enhancer in the skin. Later, 
Lavon et al
4
 showed that US (which is accompanied by 
acidic by-products of sonolysis
5
) modifies the pH 
profile of the stratum corneum and suggested that this 
changes the ionization hence lipophilicity of SLS which 
resulted in increased partitioning and activity of SLS 
into the skin and hence increased drug permeation.  
     Interestingly, SLS in combination with US has been 
found to enhance skin permeation despite the fact that 
cavitation was reduced when SLS was present at 
1%w/v
6
. The cavitation threshold (power needed to 
cause cavitation in a liquid) is known to be inversely 
proportional to the surface tension of the liquid
7
 and the 
lack of cavitation in a 1%w/v SLS solution correlates 
therefore in agreement with the literature. The lack of 
cavitation that when SLS is present at 1%w/v shows 
that, processes other than cavitation are responsible for 
the US-assisted enhanced transdermal drug permeation. 
     In most of the studies reported in the literature, SLS 
has been used at 1%w/v. Lavon et al
4
 rationalize this 
concentration as the one that is widely used in cosmetic 
and pharmaceutical products and is FDA-approved for 
topical preparation. However, SLS is a known skin 
irritant and its irritancy may be increased when used 
concurrently with US. It is also possible that 1%w/v 
SLS may not be the optimal level for maximum 
permeability coupled with minimum damage to skin. 
     Our aim was therefore to determine the optimal 
protocol for maximum vaccine permeation with 
minimum skin irritation and we investigated the effect 
of lowering concentration in the coupling medium on 
drug permeation and on skin toxicity. In vitro 
experiments using rat skin were conducted to test 
permeation of a radiolabelled protein (model vaccine). 
Other in vitro experiments using aluminium foil were 
conducted to quantify the number of pits (an indication 
of cavitation) caused by the experimental protocols. 
While in vivo studies in rats were conducted to test skin 
tolerability of the experimental conditions. 
 
Experimental Methods 
The effect of increasing SLS concentration on protein 
permeation into rat skin in vitro 
     Permeation studies using vertical Franz cells were 
conducted where full-thickness rat skin was used as the 
membrane. The donor compartment was filled with 20 
ml of coupling medium (water or SLS aqueous solution 
at different %w/v concentrations: 0.001 /0.004 /0.01/ 
0.04 /0.1 /1) and US (30% amplitude, 0.5s on, 0.5s off 
pulse wave for a total sonication time of 2 min) was 
applied. Following US application, the coupling 
medium was removed, the skin was rinsed and blotted 
dry, and 50μl of Iodine-125 labelled bovine serum 
albumin (BSA, a model antigen) was applied onto the 
skin. After 24h, the levels of radioactivity (indicating 
protein levels) in the receptor compartment and were 
measured. 
The effect of increasing SLS concentration on the 
pitting on aluminium foil 
     Pitting (the formation of pits) on aluminium foil has 
been used as an indication of cavitation that can be 
caused by US-induced cavitation
6
. In our studies, we 
measured the number of pits formed on aluminium foil 
and determined correlations, if any, between the 
number of pits, protein permeation in vitro and skin 
irritation in vivo. The experiments were conducted as 
described above except for the fact that aluminium foil 
was used as the membrane and the number of pits 
formed on the aluminium surface was visually counted 
after sonication. 
In vivo experiments to determine tolerability of 
SLS/Ultrasound combinations 
     The abdominal skin of rats was carefully shaven 24h 
before the experiment. Anaesthetized animals laid on 
their back and a custom-made flanged cylinder was 
attached to the skin. The chamber was filled with a 
coupling medium (water or SLS aqueous solution) and 
US (same protocol as for the in vitro studies) was 
applied. After sonication, the skin was washed; blotted 
dry and erythema, blood flow and Transepidermal 
Water Loss (TEWL) were measured respectively at 5, 
15, 30, 45 and 60 min post sonication. The animal was 
killed and the sonicated skin was prepared for 
histological analysis. 
 
Results and Discussion: 
      The surface tension of the different coupling media 
and the effects of increasing SLS concentration in the 
coupling medium on: (i) protein permeation in vitro, 
and (ii) number of pits formed on aluminium foil are 
shown in Figure 1. 
     We can see that: (i) as expected, increasing SLS 
concentration resulted in a marked decrease in surface 
tension when SLS concentration exceeded 0.01 %w/v. 
After this concentration, sufficient numbers of SLS 
molecules were present at the liquid-air interface to 
cause a reduction in surface tension.  
     (ii) Increasing SLS concentration (& lowering 
surface tension) in the coupling medium caused a 
decrease in pitting. During cavitation, some of the gas 
bubbles are expected to hit the aluminium foil 
membrane and thereby cause pits on the surface. While 
aluminium foil is a very different matter to animal skin, 
cavitation is a property of the liquid and therefore 
pitting on aluminium foil can be used as an indication 
of the likelihood of gas bubbles being formed, hitting 
the skin and thereby increasing drug or vaccine 
permeation into and through the skin. The decrease in 
pitting on aluminium foil indicating reduced cavitation 
with decreasing surface tension correlates with the 
literature.
3, 7
 
     SLS at concentration less than 0.004%w/v seems to 
be too low to affect permeation. Surprisingly, 
increasing SLS concentration from 0.004 %w/v to 0.04 
%w/v resulted in a marked decrease in protein 
permeation, reflecting the decreasing pitting on 
aluminium foil. A further increase in SLS concentration 
from 0.04 %w/v to 1 %w/v resulted in increased protein 
permeation, despite the absence of pitting. The partial 
correlation between the pitting and permeation profiles 
suggest that at lower SLS concentration, cavitation 
(reflected in pitting) remains the main mechanism  by 
which protein permeates into the skin. At higher 
concentrations (>0.04%w/v), however, other 
mechanisms of surfactant-induced permeation 
enhancement such as swelling of the stratum corneum 
and interaction with intercellular keratin and extraction 
of lipids from stratum corneum, enhanced by US, 
become important.   
    Surprisingly, lower concentrations of SLS (0-
0.004%w/v) resulted in similar permeation 
enhancement compared to 1%w/v SLS when combined 
with US. This is contrary to the literature, where 
addition of SLS at 1%w/v has been shown to enhance 
drug permeation
2, 3
. A direct comparison of our results 
with the literature may not be applicable as different US 
protocols and different permeants were used. In our 
case, a large permeant, a larger volume of coupling 
medium was used; a shorter probe distance and a longer 
pulse length were used. These parameters have been 
previously optimized and thus, in absence of SLS, 
sufficient US power was generated such that addition of 
SLS did not cause an observable increase in 
permeation. In addition when 1%w/v SLS was used on 
its own, very little protein permeated through the skin 
(Shown on Fig 1). No significant enhancement was 
therefore achieved.  
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Fig 1 Effects of the surface concentration of coupling 
media on surface tension (n=8), protein permeation into 
the receptor phase and aluminium foil pitting (n=5).   
     
     In vivo investigation showed increased erythema 
scores with increasing SLS concentration and 
histological analyses showed greater skin damage with 
higher SLS concentrations. LDV and TEWL however, 
did not show significant difference between the 
different coupling media. This raises issues about 
correlating TEWL and LDV measurements with skin 
damage.  
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Fig 2 Effects of the surfactant concentration of coupling 
media on TEWL (n=5) 
 
Conclusions: 
     Our results confirmed previous reports on reduced 
cavitation when SLS is included in the coupling 
medium. Our results also indicate that lower 
concentrations of SLS may be as effective as high 
concentration, when combined with optimized US 
parameters to increase permeation of large molecules. 
Lower US concentrations/US combinations were found 
to cause less damage to the skin. 
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